Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease - 18/04/17
Abstract |
Background |
A short course of potassium iodide (SSKI) has been traditionally used to prepare patients with Graves' disease for thyroidectomy. The rationale for this treatment has evolved over time; from control of hyperthyroidism to facilitating surgery by making the gland less friable and bloody.
Methods |
Randomized trial of preoperative SSKI vs no SSKI to test whether that is true.
Results |
Mean estimated blood loss in the SSKI group (62 mL) was less than in the control group (162 mL) as was the median estimated blood loss (50 vs 140 mL). Mean (142 vs 162 minutes) and median (138 vs 150 minutes) operative times were also less in the SSKI arm. Subjective difficulty of operation was similar. Multivariable comparisons of groups with analysis of covariance showed the SSKI group suffered a mean blood loss 35% of the no treatment group (P = .036), the 9.2% decrease in Operating Room (OR) time between the SSKI group and the no treatment group was not statistically different (P = .464).
Conclusions |
SSKI given before operation in patients with Graves' disease reduces blood loss during thyroidectomy.
Le texte complet de cet article est disponible en PDF.Keywords : Grave's disease, Potassium iodide, Thyroidectomy
Plan
There were no relevant financial relationships or any sources of support in the form of grants, equipment, or drugs. |
|
The authors declare no conflicts of interest. |
Vol 213 - N° 4
P. 805-809 - avril 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?